{"id":8506,"date":"2004-02-05T10:02:00","date_gmt":"2004-02-05T10:02:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=8506"},"modified":"2022-10-26T10:05:41","modified_gmt":"2022-10-26T10:05:41","slug":"treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/","title":{"rendered":"Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kanekura+T&amp;cauthor_id=14726879\">Takuro Kanekura<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14726879\/#affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kawabata+H&amp;cauthor_id=14726879\">Hisashi Kawabata<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Maruyama+I&amp;cauthor_id=14726879\">Ikuro Maruyama<\/a>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Kanzaki+T&amp;cauthor_id=14726879\">Tamotsu Kanzaki<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>J Am Acad Dermatol <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=%22J+Am+Acad+Dermatol%22%5Bjour%5D&amp;sort_order=desc\"><\/a>\u00a02004 Feb;50(2):242-6.\u00a0doi: 10.1016\/s0190-9622(03)02474-5.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Granulocyte and monocyte adsorption apheresis (GCAP) is a new extracorporeal apheresis treatment modality that removes pathogenic granulocytes. Recently, we found that GCAP is useful for treating pyoderma gangrenosum and pustular psoriasis. We thought that this treatment may also be effective for treating other disorders attributable to activated granulocytes and studied the efficacy of GCAP in 4 patients with psoriatic arthritis. Treatment with GCAP resulted in remarkable clearing of joint pain, suggesting that GCAP is valuable for treating arthritis as well as skin disorders. We present a detailed description of these patients and this novel therapy.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14726879\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/14726879\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Takuro Kanekura\u00a01,\u00a0Hisashi Kawabata,\u00a0Ikuro Maruyama,\u00a0Tamotsu Kanzaki J Am Acad Dermatol \u00a02004 Feb;50(2):242-6.\u00a0doi: 10.1016\/s0190-9622(03)02474-5. Granulocyte and monocyte adsorption apheresis (GCAP) is a new extracorporeal apheresis treatment modality that removes pathogenic granulocytes. Recently, we found that GCAP is useful for treating pyoderma gangrenosum and pustular psoriasis. We thought that this treatment may also be effective for treating other [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[608,676,276,446,672,424,105,107,673,80,662],"class_list":["post-8506","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-activated-neutrophils","scientific_tags-arthritis","scientific_tags-cases","scientific_tags-effectiveness","scientific_tags-gcap","scientific_tags-gma","scientific_tags-granulocyte","scientific_tags-monocyte","scientific_tags-pain-improvement","scientific_tags-psoriatic-arthritis","scientific_tags-skin-disorders"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Takuro Kanekura\u00a01,\u00a0Hisashi Kawabata,\u00a0Ikuro Maruyama,\u00a0Tamotsu Kanzaki J Am Acad Dermatol \u00a02004 Feb;50(2):242-6.\u00a0doi: 10.1016\/s0190-9622(03)02474-5. Granulocyte and monocyte adsorption apheresis (GCAP) is a new extracorporeal apheresis treatment modality that removes pathogenic granulocytes. Recently, we found that GCAP is useful for treating pyoderma gangrenosum and pustular psoriasis. We thought that this treatment may also be effective for treating other [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-26T10:05:41+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/\",\"name\":\"Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2004-02-05T10:02:00+00:00\",\"dateModified\":\"2022-10-26T10:05:41+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/","og_locale":"de_DE","og_type":"article","og_title":"Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis - Adacyte","og_description":"Takuro Kanekura\u00a01,\u00a0Hisashi Kawabata,\u00a0Ikuro Maruyama,\u00a0Tamotsu Kanzaki J Am Acad Dermatol \u00a02004 Feb;50(2):242-6.\u00a0doi: 10.1016\/s0190-9622(03)02474-5. Granulocyte and monocyte adsorption apheresis (GCAP) is a new extracorporeal apheresis treatment modality that removes pathogenic granulocytes. Recently, we found that GCAP is useful for treating pyoderma gangrenosum and pustular psoriasis. We thought that this treatment may also be effective for treating other [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/","og_site_name":"Adacyte","article_modified_time":"2022-10-26T10:05:41+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/","name":"Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2004-02-05T10:02:00+00:00","dateModified":"2022-10-26T10:05:41+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/treatment-of-psoriatic-arthritis-with-granulocyte-and-monocyte-adsorption-apheresis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/8506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=8506"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=8506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}